2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 9, 2011, Pages

  Hansen, Katrine B ^a,b   Rosenkilde, Mette M ^b   Knop, Filip K ^c   Wellner, Niels ^d   Diep, Thi A ^d   Rehfeld, Jens F ^e   Andersen, Ulrik B ^a   Holst, Jens J ^b   Hansen, Harald S ^d  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

2 OLEOYL GLYCEROL; CHOLECYSTOKININ; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 119; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLYCEROL; GLYCEROL DERIVATIVE; INCRETIN; OLEIC ACID; PEPTIDE YY; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; LIPID ANALYSIS; MALE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ADULT; BLOOD GLUCOSE; CYCLIC AMP; ENTEROENDOCRINE CELLS; GLUCAGON-LIKE PEPTIDE 1; GLYCERIDES; HUMANS; MALE; OLEIC ACIDS; RECEPTORS, G-PROTEIN-COUPLED;

EID: 80052521074     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-0647     Document Type: Article

References (59)

1. Wellendorph P., Johansen L.D., Bräuner-Osborne H. 2009 Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol Pharmacol 76:453-465
2. Parker H.E., Reimann F., Gribble F.M. 2010 Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med 12:e1
3. Holst J.J. 2007 The physiology of glucagon-like peptide 1. Physiol Rev 87:1409-1439 (Pubitemid 350041474)
4. Schwartz T.W., Holst B. 2010 An enteroendocrine full package solution. Cell Metab 11:445-447
5. Vilsbøll T., Krarup T., Madsbad S., Holst J.J. 2003 Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 114:115-121 (Pubitemid 36773875)
6. Vrang N., Larsen P.J. 2010 Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: Role of peripherally secreted and centrally produced peptides. Prog Neurobiol 92:442-462
7. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., Tsujimoto G. 2005 Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 11:90-94 (Pubitemid 40215843)
8. Lauffer L.M., Iakoubov R., Brubaker P.L. 2009 GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 58:1058-1066
9. Overton H.A., Babbs A.J., Doel S.M., Fyfe M.C., Gardner L.S., Griffin G., Jackson H.C., Procter M.J., Rasamison C.M., Tang-Christensen M., Widdowson P.S., Williams G.M., Reynet C. 2006 Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 3:167-175
10. Nielsen M.J., Petersen G., Astrup A., Hansen H.S. 2004 Food intake is inhibited by oral oleoylethanolamide. J Lipid Res 45:1027-1029 (Pubitemid 38679497)
11. Oveisi F., Gaetani S., Eng K.T., Piomelli D. 2004 Oleoylethanolamide inhibits food intake in free-feeding rats after oral administration. Pharmacol Res 49:461-466 (Pubitemid 38283867)
12. Maccarrone M., Gasperi V., Catani M.V., Diep T.A., Dainese E., Hansen H.S., Avigliano L. 2010 The endocannabinoid system and its relevance for nutrition. Annu Rev Nutr 30:423-440
13. Artmann A., Petersen G., Hellgren L.I., Boberg J., Skonberg C., Nellemann C., Hansen S.H., Hansen H.S. 2008 Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781:200-212
14. Diep T.A., Madsen A.N., Holst B., Kristiansen M.M., Wellner N., Hansen S.H., Hansen H.S. 2011 Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. FASEB J 25:765-774
15. Schwartz G.J., Fu J., Astarita G., Li X., Gaetani S., Campolongo P., Cuomo V., Piomelli D. 2008 The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 8:281-288
16. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. 1992 Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949 (Pubitemid 23026736)
17. Pertwee R.G., Howlett A.C., Abood M.E., Alexander S.P., Di Marzo V., Elphick M.R., Greasley P.J., Hansen H.S., Kunos G., Mackie K., Mechoulam R., Ross R.A. 2010 International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB1 and CB2. Phamacol Rev 62:588-631
18. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N.E., Schatz A.R., Gopher A., Almog S., Martin B.R., Compton D.R. 1995 Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83-90
19. Sugiura T., Kondo S., Sukagawa A., Nakane S., Shinoda A., Itoh K., Yamashita A., Waku K. 1995 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215:89-97
20. Mu H., Høy C.E. 2004 The digestion of dietary triacylglycerols. Prog Lipid Res 43:105-133 (Pubitemid 37487986)
21. Berry S.E. 2009 Triacylglycerol structure and interesterification of palmitic and stearic acid-rich fats: An overview and implications for cardiovascular disease. Nutr Res Rev 22:3-17
22. Ugleholdt R., Poulsen M.L., Holst P.J., Irminger J.C., Orskov C., Pedersen J., Rosenkilde M.M., Zhu X., Steiner D.F., Holst J.J. 2006 Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor. J Biol Chem 281:11050-11057 (Pubitemid 43855528)
23. Rosenkilde M.M., Cahir M., Gether U., Hjorth S.A., Schwartz T.W. 1994 Mutations along transmembrane segment II of the NK-1 receptor affect substance P competition with non-peptide antagonists but not substance P binding. J Biol Chem 269:28160-28164 (Pubitemid 24354551)
24. Bablok W., Passing H., Bender R., Schneider B. 1988 A general regression procedure for method transformation. Application of linear regression procedures for method comparison studies in clinical chemistry, part III. J Clin Chem Clin Biochem 26:783-790
25. Deacon C.F., Nauck M.A., Meier J., Hücking K., Holst J.J. 2000 Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 85:3575-3581
26. Orskov C., Rabenhøj L., Wettergren A., Kofod H., Holst J.J. 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43:535-539 (Pubitemid 24096293)
27. Baldissera F.G., Holst J.J. 1984 Glucagon-related peptides in the human gastrointestinal mucosa. Diabetologia 26:223-228 (Pubitemid 14167805)
28. Holst J.J., Pedersen J.H., Baldissera F., Stadil F. 1983 Circulating glucagon after total pancreatectomy in man. Diabetologia 25:396-399 (Pubitemid 14235463)
29. Orskov C., Jeppesen J., Madsbad S., Holst J.J. 1991 Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87:415-423
30. Rehfeld J.F. 1998 Accurate measurement of cholecystokinin in plasma. Clin Chem 44:991-1001 (Pubitemid 28213139)
31. Dodds W.J., Groh W.J., Darweesh R.M., Lawson T.L., Kishk S.M., Kern M.K. 1985 Sonographic measurement of gallbladder volume. AJR Am J Roentgenol 145:1009-1011 (Pubitemid 16234115)
32. Soga T., Ohishi T., Matsui T., Saito T., Matsumoto M., Takasaki J., Matsumoto S., Kamohara M., Hiyama H., Yoshida S., Momose K., Ueda Y., Matsushime H., Kobori M., Furuichi K. 2005 Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 326:744-751 (Pubitemid 39655983)
33. Chu Z.L., Carroll C., Chen R., Alfonso J., Gutierrez V., He H., Lucman A., Xing C., Sebring K., Zhou J., Wagner B., Unett D., Jones R.M., Behan D.P., Leonard J. 2010 N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. Mol Endocrinol 24:161-170
34. Yao L., Heubi J.E., Buckley D.D., Fierra H., Setchell K.D., Granholm N.A., Tso P., Hui D.Y., Woollett L.A. 2002 Separation of micelles and vesicles within lumenal aspirates from healthy humans: Solubilization of cholesterol after a meal. J Lipid Res 43:654-660
35. Rijkelijkhuizen J.M., McQuarrie K., Girman C.J., Stein P.P., Mari A., Holst J.J., Nijpels G., Dekker J.M. 2010 Effects of meal size and composition on incretin, α-cell, and β-cell responses. Metabolism 59:502-511
36. Iakoubov R., Izzo A., Yeung A., Whiteside C.I., Brubaker P.L. 2007 Protein kinase Cζ is required for oleic acid-induced secretion of glucagon-like peptide-1 by intestinal endocrine L cells. Endocrinology 148:1089-1098
37. Katsuma S., Hirasawa A., Tsujimoto G. 2005 Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329:386-390 (Pubitemid 40255465)
38. Rouzer C.A., Ghebreselasie K., Marnett L.J. 2002 Chemical stability of 2-arachidonylglycerol under biological conditions. Chem Phys Lipids 119:69-82 (Pubitemid 35247918)
39. Carr R.D., Larsen M.O., Winzell M.S., Jelic K., Lindgren O., Deacon C.F., Ahrén B. 2008 Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J Physiol Endocrinol Metab 295:E779-E784
40. Chu Z.L., Carroll C., Alfonso J., Gutierrez V., He H., Lucman A., Pedraza M., Mondala H., Gao H., Bagnol D., Chen R., Jones R.M., Behan D.P., Leonard J. 2008 A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 149:2038-2047 (Pubitemid 351574507)
41. Nauck M.A., Heimesaat M.M., Behle K., Holst J.J., Nauck M.S., Ritzel R., Hüfner M., Schmiegel W.H. 2002 Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab 87:1239-1246 (Pubitemid 36121094)
42. Chu Z.L., Jones R.M., He H., Carroll C., Gutierrez V., Lucman A., Moloney M., Gao H., Mondala H., Bagnol D., Unett D., Liang Y., Demarest K., Semple G., Behan D.P., Leonard J. 2007 A role for β-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 148:2601-2609 (Pubitemid 46984798)
43. Morgan L.M., Flatt P.R., Marks V. 1988 Nutrient regulation of the enteroinsular axis and insulin secretion. Nutr Res Rev 1:79-97
44. Shimotoyodome A., Fukuoka D., Suzuki J., Fujii Y., Mizuno T., Meguro S., Tokimitsu I., Hase T. 2009 Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice. Endocrinology 150:2118-2126
45. Roberge J.N., Brubaker P.L. 1993 Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 133:233-240 (Pubitemid 23206398)
46. Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W. 1993 Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301-307 (Pubitemid 23037285)
47. Mortensen K., Christensen L.L., Holst J.J., Orskov C. 2003 GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114:189-196 (Pubitemid 36773884)
48. Fu-Cheng X., Anini Y., Chariot J., Voisin T., Galmiche J.P., Rozé C. 1995 Peptide YY release after intraduodenal, intraileal, and intracolonic administration of nutrients in rats. Pflugers Arch 431:66-75
49. Berglund M.M., Hipskind P.A., Gehlert D.R. 2003 Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med (Maywood) 228:217-244 (Pubitemid 36314489)
50. Yen C.L., Cheong M.L., Grueter C., Zhou P., Moriwaki J., Wong J.S., Hubbard B., Marmor S., Farese Jr R.V. 2009 Deficiency of the intestinal enzyme acyl CoA:Monoacylglycerol acyltransferase-2 protects mice from metabolic disorders induced by high-fat feeding. Nat Med 15:442-446
51. Cox H.M., Tough I.R., Woolston A.M., Zhang L., Nguyen A.D., Sainsbury A., Herzog H. 2010 Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses. Cell Metab 11:532-542
52. Beglinger C., Degen L. 2004 Fat in the intestine as a regulator of appetite - Role of CCK. Physiol Behav 83:617-621 (Pubitemid 40038512)
53. Rehfeld J.F. 2004 Clinical endocrinology and metabolism. Cholecystokinin. Best Pract Res Clin Endocrinol Metab 18:569-586
54. Ahrén B., Pettersson M., Uvnäs-Moberg K., Gutniak M., Efendic S. 1991 Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man. Diabetes Res Clin Pract 13:153-161
55. Liddle R.A., Gertz B.J., Kanayama S., Beccaria L., Gettys T.W., Taylor I.L., Rushakoff R.J., Williams V.C., Coker L.D. 1990 Regulation of pancreatic endocrine function by cholecystokinin: Studies with MK-329, a nonpeptide cholecystokinin receptor antagonist. J Clin Endocrinol Metab 70:1312-1318
56. Rushakoff R.J., Goldfine I.D., Carter J.D., Liddle R.A. 1987 Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans. J Clin Endocrinol Metab 65:395-401 (Pubitemid 17135160)
57. Larsson L.I., Rehfeld J.F. 1979 Peptidergic and adrenergic innervation of pancreatic ganglia. Scand J Gastroenterol 14:433-437 (Pubitemid 9232236)
58. Rehfeld J.F., Larsson L.I., Goltermann N.R., Schwartz T.W., Holst J.J., Jensen S.L., Morley J.S. 1980 Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK. Nature 284:33-38 (Pubitemid 10098763)
59. Beglinger S., Drewe J., Schirra J., Göke B., D'Amato M., Beglinger C. 2010 Role of fat hydrolysis in regulating glucagon-like peptide-1 secretion. J Clin Endocrinol Metab 95:879-886